BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 8510925)

  • 21. PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter.
    Chen JH; Wright CD
    Oncogene; 1993 Dec; 8(12):3375-83. PubMed ID: 8247540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1.
    McNagny KM; Sieweke MH; Döderlein G; Graf T; Nerlov C
    EMBO J; 1998 Jul; 17(13):3669-80. PubMed ID: 9649437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of the ets genes and their products.
    Watson DK; Ascione R; Papas TS
    Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
    McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
    Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of a C. elegans GATA transcription factor, ELT-1, expressed in yeast.
    Shim YH; Bonner JJ; Blumenthal T
    J Mol Biol; 1995 Nov; 253(5):665-76. PubMed ID: 7473742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
    Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
    Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
    Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
    Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.
    Rameil P; Lécine P; Ghysdael J; Gouilleux F; Kahn-Perlès B; Imbert J
    Oncogene; 2000 Apr; 19(17):2086-97. PubMed ID: 10815800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
    Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES
    Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes.
    Wang J; Shannon MF; Young IG
    Int Immunol; 2006 Feb; 18(2):313-23. PubMed ID: 16373364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
    Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
    Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trans-activation of heparanase promoter by ETS transcription factors.
    Lu WC; Liu YN; Kang BB; Chen JH
    Oncogene; 2003 Feb; 22(6):919-23. PubMed ID: 12584571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and functional analysis of the p42Ets-1 variant of the mouse Ets-1 transcription factor.
    Lionneton F; Lelièvre E; Baillat D; Stehelin D; Soncin F
    Oncogene; 2003 Dec; 22(57):9156-64. PubMed ID: 14668797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ets-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter.
    Baillat D; Laitem C; Leprivier G; Margerin C; Aumercier M
    Biochem Biophys Res Commun; 2009 Jan; 378(2):213-7. PubMed ID: 19022222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ets1, when fused to the GAL4 DNA binding domain, efficiently enhances galactose promotor dependent gene expression in yeast.
    Seneca S; Punyammalee B; Bailly M; Ghysdael J; Crabeel M
    Oncogene; 1991 Mar; 6(3):357-60. PubMed ID: 1901401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif.
    Fisher RJ; Mavrothalassitis G; Kondoh A; Papas TS
    Oncogene; 1991 Dec; 6(12):2249-54. PubMed ID: 1766672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse models in the study of the Ets family of transcription factors.
    Bartel FO; Higuchi T; Spyropoulos DD
    Oncogene; 2000 Dec; 19(55):6443-54. PubMed ID: 11175360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter.
    Raouf A; Li V; Kola I; Watson DK; Seth A
    Oncogene; 2000 Apr; 19(15):1969-74. PubMed ID: 10773887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.